SynthesisBMC neurology2026
Insulin resistance and the risk of dementia: a systematic review and meta-analysis of prospective cohort studies.
Synthesis in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMechanistic and cross-sectional studies have indicated a correlation between insulin resistance and dementia; however, further evidence from prospective studies is needed to elucidate the relationship between insulin resistance and the risk of developing dementia.
methodsA systematic review and meta-analysis were conducted. Searches were performed in PubMed, EMBASE, and the Cochrane Library for relevant articles published up to December 20th, 2025. Cohort studies investigating the risk of dementia onset associated with insulin resistance were included.
resultsA total of ten studies were included in the meta-analysis. Insulin resistance was associated with an increased risk of all-cause dementia (HR = 1.11, 95% CI 1.03-1.21, 9 studies included) and Alzheimer's disease (HR = 1.23, 95% CI 1.01-1.50, 7 studies included). A similar association was observed between insulin resistance and the risk of vascular dementia (HR = 1.04, 95% CI 1.01-1.07, 4 studies included).
conclusionThe available evidence suggested that insulin resistance might be associated with an increased risk of all-cause dementia, Alzheimer's disease, and vascular dementia. Further well-designed prospective studies are warranted to clarify the causal relationship between insulin resistance and dementia.
trial registrationThe study was registered with PROSPERO under the registration number CRD42024550842 on June 5th, 2024.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.